Skip to content

QIF-T0014

high

Envelope modulation (stealth carrier)

Tier 3 — Demonstrated (Lab-proven)

Legacy status: DEMONSTRATED

Any carrier frequency modulated at neural frequency. Tissue demodulates the envelope. Stealth: carrier looks normal, attack is in the modulation. Lowest barrier to entry (PUBLIC access). tACS therapeutic principle weaponized.

Technique Details

Tactic
QIF-E.RD
Status
DEMONSTRATED
Bands
S1, S2, N1, N2, N3, N4, N5, N6, N7

✚ Therapeutic Application

Amplitude-modulated carrier signal where neural tissue demodulates the envelope at biologically active frequencies

Clinical Analog

tACS with carrier-envelope paradigm

Treats

  • pain modulation
  • sleep induction
  • cognitive enhancement

Neural Impact

9 of 7 neural bands affected

S1 S2 N1 N2 N3 N4 N5 N6 N7

Drag to rotate. Click a region to learn more.

Click or hover over a glowing region to see the attack techniques targeting it and their severity.

DSM-5-TR Diagnostic Mappings

Diagnostic category references for threat modeling, not diagnostic claims.

F45 Somatoform disorders F44.4 Conversion Disorder F82 Developmental Coordination Disorder F84 Pervasive developmental disorders F20 Schizophrenia Spectrum F44 Dissociative Disorders F90 ADHD F10 Alcohol-related disorders (F10) F42 OCD F95 Tic Disorders F32 Major Depressive Disorder F41.1 Generalized Anxiety Disorder F43.10 PTSD F41.0 Panic Disorder F01 Vascular dementia F30 Manic episode F50 Eating Disorders F52 Sexual Dysfunctions F60 Personality Disorders F63 Impulse-Control Disorders F43 PTSD / Trauma F80 Communication Disorders F98.4 Stereotyped movement disorders

Pathway: N7 (PFC/M1) → executive function; N6 (hippocampus/amygdala) → emotion regulation

Following Poldrack (2006), brain region disruption does not uniquely predict psychiatric outcomes.

Scoring

NISS v1.1 NISS:1.1/BI:H/CR:H/CD:H/CV:I/RV:P/NP:S
CVSS v4.0 CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:N/VI:H/VA:L/SC:N/SI:H/SA:L
8.1High
PINSPINS triggers when Biological Impact is High/Critical or Reversibility is Irreversible. Indicates potential lasting harm to neural safety.
BICRCDCVRVNP
 

Governance

Neurorights at Risk

This technique threatens 5 of the 4 proposed neurorights (Ienca & Andorno, 2017).

MP Mental Privacy CL Cognitive Liberty MI Mental Integrity PC Psychological Continuity DI DI
Consent Complexity
1.20 / 4.0

FDORA §3305 Compliance

Non-Cyber Device (missing: software)
Regulatory Coverage
0.7 / 1.0
524B Requirements
TM VA SA PM
Regulatory Gaps
  • ! CVSS cannot express neural-specific impacts
  • ! High neural impact (NISS >= 7.0) without IEC 62443 coverage

Population Vulnerability

CRB vulnerability adjustment (γ=0.30) accounts for age, diagnosis severity, consent capacity, and device dependency.

Population NISS Base Adjusted Severity Delta
Adult (Default) 8.1 8.1 High -
Child (10yr) + ADHD 8.1 9.5 Critical ▲ +1.43
Adult with ALS 8.1 9.4 Critical ▲ +1.31

Validation Status

Theoretical / Not yet validated. This technique has not been independently tested. See the validation dashboard for what has been tested.

Qinnovate Neural Security Atlas Edit this on GitHub